United Therapeutics Corporation (NASDAQ: UTHR) announced that The New England Journal of Medicine published full results from its phase 3 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE